Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesSilent Cerebral Infarcts in Patients With Pulmonary Embolism and a Patent Foramen Ovale. A Prospective Diffusion-Weighted MRI Study
Stroke, 09/28/09
Clergeau MR et al. – In pulmonary embolism, cerebral embolic events are more frequent than the apparent neurological complication rate. The prevalence of silent brain infarcts is closely related to the presence of a PFO suggesting a high incidence of unsuspected paradoxical emboli in those patients.
Related Articles
Patent foramen ovale and cryptogenic stroke: a complex neuro–cardio–vascular problem
Expert Review of Cardiovascular Therapy, 11/12/09
Relevance Score: 89%
Intra-operative cerebral microembolisation during primary hybrid total hip arthroplasty compared with primary hip resurfacing
Acta Orthopaedica Belgica, 11/17/09
Relevance Score: 88%
Diffusion-weighted imaging findings differ between stroke attributable to spontaneous cervical artery dissection and patent foramen ovale
European Journal of Neurology, 11/09/09
Relevance Score: 88%
Anomalous Origin of a Coronary Artery from the Right Branchiocephalic Trunk Associated with Complex Congenital Heart Disease
Pediatric Cardiology, 11/02/09
Relevance Score: 87%
Endovascular embolization with a vascular plug corrects a PAVM
JAAPA, 10/26/09
Relevance Score: 87%
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
The clinical course of pulmonary embolism patients anticoagulated for 1 year: results of a prospective, observational, cohort study
Journal of Thrombosis and Haemostasis, 12/18/09
Volumetric or time-based capnography for excluding pulmonary embolism in outpatients
Journal of Thrombosis and Haemostasis, 12/18/09
Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil
Rheumatology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor